Copyright
©The Author(s) 2024.
World J Methodol. Jun 20, 2024; 14(2): 92612
Published online Jun 20, 2024. doi: 10.5662/wjm.v14.i2.92612
Published online Jun 20, 2024. doi: 10.5662/wjm.v14.i2.92612
Table 1 Patient demographics and number of comorbidities by cancer type, n (%)
| Colorectal | HBP | OG | Breast | ||
| Total number | 53 (100) | 13 (100) | 9 (100) | 20 (100) | |
| Age (yr) | 40-49 | 3 (5.7) | 2 (15.4) | 5 (25.0) | |
| 50-59 | 3 (5.7) | 2 (15.4) | 8 (40.0) | ||
| 60-69 | 13 (24.5) | 5 (38.5) | 5 (55.6) | 3 (15.0) | |
| 70-79 | 22 (41.5) | 3 (23.1) | 3 (33.3) | 4 (20.0) | |
| 80-89 | 11 (20.8) | 1 (7.7) | 1 (11.1) | ||
| 90-99 | 1 (1.9) | ||||
| Sex | Female | 18 (34) | 7 (53.8) | 2 (22.2) | 19 (95.0) |
| Male | 35 (66) | 6 (46.2) | 7 (77.8) | 1 (5.0) | |
| ECOG perfor-mance score | 0 | 13 (24.5) | 5 (38.5) | 3 (33.3) | 19 (95.0) |
| 1 | 21 (39.6) | 6 (46.2) | 4 (44.4) | 1 (5.0) | |
| 2 | 17 (32.1) | 2 (15.4) | 2 (22.2) | ||
| 3 | 2 (3.8) | ||||
| ASA | I | 7 (13.2) | 1 (7.7) | 0 | 4 (20.0) |
| II | 25 (47.2) | 6 (46.2) | 6 (66.7) | 13 (65.0) | |
| III | 17 (32.1) | 5 (38.5) | 2 (22.2) | 3 (15.0) | |
| IV | 4 /7.5) | 1 (7.7) | 1 (11.1) | ||
| BMI | < 18.5 | 0 | 1 (7.7) | ||
| 18.5-24.9 | 10 (18.9) | 4 (30.8) | 3 (33.3) | 7 (35.0) | |
| 25-29.9 | 24 (45.3) | 5 (38.5) | 5 (55.6) | 8 (40.0) | |
| 30-34.9 | 15 (28.3) | 1 (7.7) | 1 (11.1) | 1 (5.0) | |
| 35-39.9 | 4 (28.3) | 1 (7.7) | 3 (15.0) | ||
| ≥ 40 | 0 | 1 (7.7) | 1 (5.0) | ||
| Number of comorbidities | Mean (SD), range | 3.13 (1.34) 1-6 | 2.85 (1.4), 1-5 | 3 (1.22) 1-5 | 1.85 (1.14) 0-4 |
- Citation: Trébol J, Carabias-Orgaz A, Esteban-Velasco MC, García-Plaza A, González-Muñoz JI, Sánchez-Casado AB, Parreño-Manchado FC, Eguía-Larrea M, Alcázar-Montero JA. Digestive and breast cancer patients managed during the first wave of COVID-19 pandemic: Short and middle term outcomes. World J Methodol 2024; 14(2): 92612
- URL: https://www.wjgnet.com/2222-0682/full/v14/i2/92612.htm
- DOI: https://dx.doi.org/10.5662/wjm.v14.i2.92612